Literature DB >> 16391156

Antihypertensive medication use among US adults with hypertension.

Qiuping Gu1, Ryne Paulose-Ram, Charles Dillon, Vicki Burt.   

Abstract

BACKGROUND: High blood pressure can be controlled through existing antihypertensive drug therapy. This study examined trends in prescribed antihypertensive medication use among US adults with hypertension and compared drug utilization patterns with recommendations of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. METHODS AND
RESULTS: Persons aged > or =18 years from the National Health and Nutrition Examination Surveys were identified as hypertensive on the basis of either a blood pressure > or =140/90 mm Hg or self-reported current treatment for hypertension with a prescription medication. In 1999-2002, 62.9% of US hypertensive adults took a prescription antihypertensive medication compared with 57.3% during 1988-1994 (P<0.01). Men had the greatest increase in antihypertensive medication use (47.5%, 1988-1994 versus 57.9%, 1999-2002 [P<0.001]). In both surveys, antihypertensive medication use increased with age, was lower among men than among women, and was lower among Mexican Americans than among non-Hispanic whites and blacks. Multiple antihypertensive drug use increased from 29.1% to 35.8% (P<0.001). Polytherapy with a calcium channel blocker, beta-blocker, or angiotensin-converting enzyme inhibitor significantly increased by 30%, 42%, and 68%, respectively, whereas monotherapy with a diuretic or beta-blocker significantly decreased. For hypertensives with diabetes, congestive heart failure, or a prior heart attack, the utilization patterns closely followed the Sixth Joint National Committee guideline recommendations.
CONCLUSIONS: Antihypertensive medication use and multiple antihypertensive medication use among US hypertensive adults increased over the past 10 years, but disparities by sociodemographic factors continue to exist.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391156     DOI: 10.1161/CIRCULATIONAHA.105.542290

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

1.  The effect of screening for cardio-renal risk factors on drug use in the general population.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-12       Impact factor: 4.335

2.  Replication and reproducibility issues in the relationship between C-reactive protein and depression: A systematic review and focused meta-analysis.

Authors:  Sarah R Horn; Madison M Long; Benjamin W Nelson; Nicholas B Allen; Philip A Fisher; Michelle L Byrne
Journal:  Brain Behav Immun       Date:  2018-06-19       Impact factor: 7.217

3.  How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).

Authors:  Andrea L Schaffer; Sallie-Anne Pearson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

4.  Trends in Prevalence of Chronic Kidney Disease in the United States.

Authors:  Daniel Murphy; Charles E McCulloch; Feng Lin; Tanushree Banerjee; Jennifer L Bragg-Gresham; Mark S Eberhardt; Hal Morgenstern; Meda E Pavkov; Rajiv Saran; Neil R Powe; Chi-Yuan Hsu
Journal:  Ann Intern Med       Date:  2016-08-02       Impact factor: 25.391

5.  Racial differences in incident heart failure among young adults.

Authors:  Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

Review 6.  Ten putative contributors to the obesity epidemic.

Authors:  Emily J McAllister; Nikhil V Dhurandhar; Scott W Keith; Louis J Aronne; Jamie Barger; Monica Baskin; Ruth M Benca; Joseph Biggio; Mary M Boggiano; Joe C Eisenmann; Mai Elobeid; Kevin R Fontaine; Peter Gluckman; Erin C Hanlon; Peter Katzmarzyk; Angelo Pietrobelli; David T Redden; Douglas M Ruden; Chenxi Wang; Robert A Waterland; Suzanne M Wright; David B Allison
Journal:  Crit Rev Food Sci Nutr       Date:  2009-11       Impact factor: 11.176

7.  Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.

Authors:  Sumanta K Pal; Jonathan Yamzon; Virginia Sun; Courtney Carmichael; Junmi Saikia; Betty Ferrell; Paul Frankel; Joann Hsu; Przemyslaw Twardowski; Cy A Stein; Kim Margolin
Journal:  Clin Genitourin Cancer       Date:  2012-10-11       Impact factor: 2.872

8.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

9.  Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the Framingham study.

Authors:  Cheol Ung Choi; Chang Gyu Park
Journal:  BMC Neurol       Date:  2009-04-22       Impact factor: 2.474

10.  Laboratory testing in newly treated elderly hypertensive patients without co-morbidities: a population-based cohort study.

Authors:  Finlay Aleck McAlister; Karen Tu; Sumit R Majumdar; Rajdeep Padwal; Zhongliang Chen; Norman R C Campbell
Journal:  Open Med       Date:  2007-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.